» Articles » PMID: 37069601

Unlocking the Potential of TIPS Placement As a Bridge to Elective and Emergency Surgery in Cirrhotic Patients: a Meta-analysis and Future Directions for Endovascular Resuscitation in Acute Care Surgery

Overview
Publisher Biomed Central
Specialty General Surgery
Date 2023 Apr 18
PMID 37069601
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In this systematic review and meta-analysis, we examined the evidence on transjugular intrahepatic portosystemic shunt (TIPS) as a bridge to elective and emergency surgery in cirrhotic patients. We aimed to assess the perioperative characteristics, management approaches, and outcomes of this intervention, which is used to achieve portal decompression and enable the safe performance of elective and emergent surgery.

Methods: MEDLINE and Scopus were searched for studies reporting the outcomes of cirrhotic patients undergoing elective and emergency surgery with preoperative TIPS. The risk of bias was evaluated using the methodological index for non-randomized studies of interventions, and the JBI critical appraisal tool for case reports. The outcomes of interest were: 1. Surgery after TIPS; 2. Mortality; 3. Perioperative transfusions; and 4. Postoperative liver-related events. A DerSimonian and Laird (random-effects) model was used to perform the meta-analyses in which the overall (combined) effect estimate was presented in the form of an odds ratio (summary statistic).

Results: Of 426 patients (from 27 articles), 256 (60.1%) underwent preoperative TIPS. Random effects MA showed significantly lower odds of postoperative ascites with preoperative TIPS (OR = 0.40, 95% CI 0.22-0.72; I2 = 0%). There were no significant differences in 90-day mortality (3 studies: OR = 0.76, 95% CI 0.33-1.77; I2 = 18.2%), perioperative transfusion requirement (3 studies: OR = 0.89, 95% CI 0.28-2,84; I2 = 70.1%), postoperative hepatic encephalopathy (2 studies: OR = 0.97, 95% CI 0.35-2.69; I2 = 0%), and postoperative ACLF (3 studies: OR = 1.02, 95% CI 0.15-6.8, I2 = 78.9%).

Conclusions: Preoperative TIPS appears safe in cirrhotic patients who undergo elective and emergency surgery and may have a potential role in postoperative ascites control. Future randomized clinical trials should test these preliminary results.

Citing Articles

Use of Transjugular Intrahepatic Portosystemic Shunt (TIPS) to Provide for Safe Pancreaticoduodenectomy in Patients with Portal Hypertension.

Shaker A, Vasudevan S, Verastegui A, Fajardo D, Stauffer J J Gastrointest Cancer. 2025; 56(1):59.

PMID: 39909940 DOI: 10.1007/s12029-025-01182-3.


Preventing the progression of cirrhosis to decompensation and death.

Villanueva C, Tripathi D, Bosch J Nat Rev Gastroenterol Hepatol. 2025; .

PMID: 39870944 DOI: 10.1038/s41575-024-01031-x.


Recent TIPS increases postoperative mortality: A national cohort study.

Tang H, Kaplan D, Abu-Gazala S, Mahmud N Hepatol Commun. 2024; 8(12).

PMID: 39621306 PMC: 11608713. DOI: 10.1097/HC9.0000000000000577.


Case report: Management of liver cancer complicated by gastric varices rupture and bleeding: transjugular intrahepatic portosystemic shunt utilizing the mesenteric venous pathway.

Sun G, Wang J, Zhang B, Zheng N Front Med (Lausanne). 2024; 11:1388584.

PMID: 38962741 PMC: 11220234. DOI: 10.3389/fmed.2024.1388584.


A systematic review of preoperative transjugular intrahepatic portosystemic shunt prior to extrahepatic, abdominal surgery in patients with cirrhosis.

Haider M, Nur Y, Syed H, Khan K Saudi J Gastroenterol. 2024; 30(5):275-282.

PMID: 38916207 PMC: 11534189. DOI: 10.4103/sjg.sjg_114_24.


References
1.
Azoulay D, Buabse F, Damiano I, Smail A, Ichai P, Dannaoui M . Neoadjuvant transjugular intrahepatic portosystemic shunt: a solution for extrahepatic abdominal operation in cirrhotic patients with severe portal hypertension. J Am Coll Surg. 2001; 193(1):46-51. DOI: 10.1016/s1072-7515(01)00911-5. View

2.
Iwakiri Y, Trebicka J . Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy. JHEP Rep. 2021; 3(4):100316. PMC: 8318926. DOI: 10.1016/j.jhepr.2021.100316. View

3.
Kirkham J, Davis K, Altman D, Blazeby J, Clarke M, Tunis S . Core Outcome Set-STAndards for Development: The COS-STAD recommendations. PLoS Med. 2017; 14(11):e1002447. PMC: 5689835. DOI: 10.1371/journal.pmed.1002447. View

4.
Minicozzi A, Veraldi G, Borzellino G . Minimally invasive treatment of portal hypertension, abdominal aortic aneurysm, and colon cancer: a case report. Surg Laparosc Endosc Percutan Tech. 2010; 20(4):281-3. DOI: 10.1097/SLE.0b013e3181e1348d. View

5.
Ripoll C, Groszmann R, Garcia-Tsao G, Grace N, Burroughs A, Planas R . Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis. Gastroenterology. 2007; 133(2):481-8. DOI: 10.1053/j.gastro.2007.05.024. View